CPSC announces voluntary recall of Vicks Dayquil Cold & Flu Liquicaps

NewsGuard 100/100 Score
The U.S. Consumer Product Safety Commission, in cooperation with the firm named below, today announced a voluntary recall of the following consumer product. Consumers should stop using the recalled products immediately unless otherwise instructed.

Name of product: Vicks Dayquil Cold & Flu 24-Count Bonus Pack Liquicaps

Units: About 700,000 packages

Manufacturer: The Procter & Gamble Co., of Cincinnati, Ohio

Hazard: The cold and flu medicine contains acetaminophen and is not in child-resistant packaging and lacks the statement, "This Package for Households Without Young Children," as required by the Poison Prevention Packaging Act. This medicine could cause serious health problems or death to a child if several of the capsules are swallowed.

Incidents/Injuries: None reported.

Description: The recall involves Vicks Dayquil Cold & Flu 24-Count Bonus Pack Liquicaps. The medicine comes in orange packaging with the green Vicks symbol and has the following UPC#: 3 23900 01087 1. No other Vick's product is included in this recall.

Sold at: Drug stores, grocery stores and other retailers nationwide between September 2008 and December 2009 for about $5.

Manufactured in: Canada

Remedy: Consumers should keep this product out of the reach of children. Consumers who purchased the product with the expectation that it would be in child-resistant packaging can contact Procter & Gamble for a full refund or a replacement coupon. Adult consumers can continue to use the product as directed.

SOURCE U.S. Consumer Product Safety Commission

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Study reveals BCG vaccine's unexpected role in fighting influenza